PF-06372865 In Subjects With Chronic Low Back Pain

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

PF-06372865 In Subjects With Chronic Low Back Pain

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Naproxen; PF-06372865

Criteria

Inclusion Criteria:

-

Exclusion Criteria:

-